Navigation Links
Oncothyreon to present at BIO Investor Forum 2008
Date:10/24/2008

SEATTLE, Oct. 24 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the 7th Annual BIO Investor Forum in San Francisco on Friday, October 31, 2008 at 8:00 a.m. Pacific Time.

A live and archived webcast of Dr. Kirkman's presentation can be accessed at http://www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
2. Oncothyreon announces prioritization plan for development programs
3. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
4. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
5. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
6. Oncothyreon to receive milestone payment
7. Oncothyreon Reports First Quarter 2008 Financial Results
8. Oncothyreon files investigational new drug application for PX-866 oncology compound
9. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
10. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
11. Oncothyreon announces effectiveness of shelf registration statement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...CKHOLM, November 20 Karolinska Dev...stment Fund (EIF) has entered into a,co-investment...d will be,managed by Karolinska Development and us...tage pharmaceutical and medical technology compani...o-investment fund. The agreement,represents EIF,s ...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Dom...o;The Role of Process Analytical Technology (PAT) ... December 1, 2009. , (PRW...rocess Analytical Technology (PAT) in Green Chemis...Process Analytical Technology (PAT) case studies w...
(Date:11/19/2009)...v. 19 Omeros Corporation...ial results for the third quarter ended September ... 2009, Omeros reported a net loss of $3.9 million,...$7.4 million, or $2.54 per share, for the same per...0, 2009, the Company reported a net loss of $15.5 ...
(Date:11/19/2009)...ov. 19 NeoStem, Inc. (NY...the following letter to its shareholders, discussi... of China Biopharmaceuticals Holdings, Inc. (CHBP)...n the People,s Republic of China. The merger gives... Pharmaceutical Co. Ltd., CHBP,s primary operating...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...market Salugen,s DNA-customized nutritional soluti... SAN DIEGO, Oct. 19 Salugen(R) ( http://www.salu...y, announces today a partnership,with DNA Dimensio...,nutritional gene testing and DNA-customized nutri...will offer GenoTrim(R), a DNA-customized,nutrition...
...ress by James Cornelius, CEO of Bristol-Myers Squi... an,emerging specialty pharmaceutical company focu...gh the development and commercialization of treatm... announced that Robert,Bitterman, the Company,s Pr...nting at the Paramount BioSciences Healthcare Conf...
...Oct. 19 An affiliate of,Phlo Corporation (Pink Sh...he distribution of its vitality product, AQUISS(TM...ide coverage within Northern California and has,be... commencing with the,Palm Desert/Palm Springs area... at a Merchandiser,Holiday Meeting, which was inst...
Other Biology Technology:Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area 2Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area 3Cutanea to Present at the Paramount BioSciences Healthcare Conference 2AQUISS Continues Expansion Into New Territory 2
(Date:11/19/2009)...entists are revealing the genetic instructions ins... or maize, has one of the most complex sequences o...Madison genomicist David Schwartz, who was one of ...l Science . , "The maize genome is a true maze ... troubled would-be sequencers for years," says Sch...
(Date:11/19/2009)...genetic diversity in maize, also known as corn, re... a gene map that should pave the way to significan...f food, fuel, animal feed and fiber around the wor...own as a haplotype map, charts genetic diversity a...nes of maize. The research team, led by U.S. Depar...
(Date:11/19/2009)...e,s Ross Hardison, T. Ming Chu Professor of Bioche...ep toward unraveling how regulatory proteins contr...ent and growth. Working with collaborators includi...,s Hospital of Philadelphia, they focused specific... cells (erythrocytes). These cells contain large a...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Sedgwick CMS Integrates Medicare Compliance Solution With Claims Management Services 59928 1Sedgwick CMS Integrates Medicare Compliance Solution With Claims Management Services 59928 2LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 1LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 2Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 1Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 2Myriant Technologies LLC Announces Appointment of Science Advisory Board Members 14565 3
...sons a protein called amyloid beta aggregates into...e plaques are one of the hallmarks of Alzheimers d...rst time that the deadly transformation of amyloid...eraction between amyloid beta and another protein ...be done, these new findings may open the door to n...
...s energy levels cycle on a 24-hour, or circadian, ...d by oxygen. Now, researchers at the University of... protein called Rev-erb coordinates the daily cycl...he bodys correct metabolism. , The research appe... of print publication in Science. , Many studies,...
...ldrens have issued the first study showing that a ...n), also plays an important role in the inflammato...s. Inflammatory joint disease appears to be driven...in matrices through a specific integrin receptor, ... of Clinical Investigation, researchers suggest th...
Other Biology News:A novel way found to prevent protein plaques implicated in Alzheimer's 2A novel way found to prevent protein plaques implicated in Alzheimer's 3A mechanism to explain biological 'cross-talk' between 24-hour body cycle and metabolism 2Blood clotting protein linked to rheumatoid arthritis 2
MiniMACS Separation Unit from Miltenyi Biotec
Experion RNA HighSens Chips, 10 from Bio-Rad
...ith carbonyl diimidazole chemistry that covalently...y contains the same binding chemistry as the forme...er coating. These arrays are 8 spot chips with 2 m...umn of a standard 96-well microplate (9 mm well pi...
Silver Stain Kit from Bio-Rad
Biology Products: